The Effect of Food on the Single-dose Pharmacokinetics of BI 3731579 Administered Orally in Healthy Male Subjects (an Open Label, Two-period, Two-sequence Crossover Trial)
Latest Information Update: 08 May 2025
At a glance
- Drugs BI 3731579 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
Most Recent Events
- 29 Apr 2025 Status changed from active, no longer recruiting to completed.
- 17 Apr 2025 Status changed from recruiting to active, no longer recruiting.
- 01 Apr 2025 Status changed from not yet recruiting to recruiting.